Institutional Ownership Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). We have compiled data on the 278 institutions that hold shares in the stock, with a total of 167 Million shares, which have been reported (via 13F filing form) to have a value of $1.57 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
21,890,422
shares
|
$202 Million
0.0% of portfolio
|
Q4 2024
Added 7.8%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
19,956,255
shares
|
$184 Million
0.0% of portfolio
|
Q2 2024
Added 8.22%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
11,865,000
shares
|
$109 Million
1.3% of portfolio
|
Q3 2024
Reduced 5.61%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
9,085,368
shares
|
$83.7 Million
4.33% of portfolio
|
Q3 2024
Added 2.93%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Feb 14, 2025 Q4 2024 |
8,144,442
shares
|
$75 Million
1.52% of portfolio
|
Q4 2024
Added 0.11%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
7,498,967
shares
|
$69.1 Million
0.0% of portfolio
|
Q4 2024
Reduced 15.26%
|
|
|
Alkeon Capital Management LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
7,093,822
shares
|
$65.3 Million
0.11% of portfolio
|
Q3 2024
Reduced 0.08%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,286,536
shares
|
$48.7 Million
0.04% of portfolio
|
Q2 2023
Reduced 5.91%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
4,823,735
shares
|
$44.4 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.29%
|
|
|
Rp Management, LLC
New York, NY |
Feb 03, 2025 Q4 2024 |
3,846,154
shares
|
$35.4 Million
38.54% of portfolio
|
Q4 2021
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,419,046
shares
|
$31.5 Million
0.01% of portfolio
|
Q4 2024
Reduced 28.99%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Feb 05, 2025 Q4 2024 |
3,182,617
shares
|
$29.3 Million
0.01% of portfolio
|
Q4 2024
Reduced 4.66%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Feb 05, 2025 Q4 2024 |
2,941,396
shares
|
$27.1 Million
0.19% of portfolio
|
Q4 2024
Reduced 10.26%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,677,996
shares
|
$24.7 Million
0.8% of portfolio
|
Q4 2024
Reduced 26.07%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
2,499,812
shares
|
$23 Million
0.05% of portfolio
|
Q4 2024
Added 14.62%
|
|
|
Rice Hall James & Associates, LLC
|
Jan 31, 2025 Q4 2024 |
2,081,316
shares
|
$19.2 Million
0.95% of portfolio
|
Q4 2024
Reduced 3.81%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
2,004,911
shares
|
$18.5 Million
0.0% of portfolio
|
Q4 2024
Added 7.74%
|
|
|
Eversept Partners, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,980,312
shares
|
$18.2 Million
1.5% of portfolio
|
Q4 2024
Added 269.87%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,979,992
shares
|
$18.2 Million
0.0% of portfolio
|
Q4 2024
Added 4.87%
|
|
|
Stifel Financial Corp
St. Louis, MO |
Feb 13, 2025 Q4 2024 |
1,842,986
shares
|
$17 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.02%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,774,214
shares
|
$16.3 Million
0.03% of portfolio
|
Q4 2024
Added 0.76%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Feb 14, 2025 Q4 2024 |
1,720,581
shares
|
$15.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.93%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,665,732
shares
|
$15.3 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.22%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Feb 14, 2025 Q4 2024 |
1,579,960
shares
|
$14.6 Million
0.05% of portfolio
|
Q4 2024
Reduced 11.88%
|
|
|
Segall Bryant & Hamill, LLC
Chicago, IL |
Feb 11, 2025 Q4 2024 |
1,422,196
shares
|
$13.1 Million
0.15% of portfolio
|
Q4 2024
Reduced 4.57%
|